» Articles » PMID: 24677538

AERS Spider: an Online Interactive Tool to Mine Statistical Associations in Adverse Event Reporting System

Overview
Publisher Wiley
Date 2014 Mar 29
PMID 24677538
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Exploration of the Adverse Event Reporting System (AERS) data by a wide scientific community is limited due to several factors. First, AERS data must be intensively preprocessed to be converted into analyzable format. Second, application of the currently accepted disproportional reporting measures results in false positive signals.

Methods: We proposed a data mining strategy to improve hypothesis generation with respect to potential associations.

Results: By numerous examples, we illustrate that our strategy controls the false positive signals. We implemented a free online tool, AERS spider (www.chemoprofiling.org/AERS).

Conclusions: We believe that AERS spider would be a valuable tool for drug safety experts.

Citing Articles

Navigating duplication in pharmacovigilance databases: a scoping review.

Kiguba R, Isabirye G, Mayengo J, Owiny J, Tregunno P, Harrison K BMJ Open. 2024; 14(4):e081990.

PMID: 38684275 PMC: 11086478. DOI: 10.1136/bmjopen-2023-081990.


Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach.

Giunchi V, Fusaroli M, Hauben M, Raschi E, Poluzzi E Drug Saf. 2023; 46(10):921-926.

PMID: 37651086 DOI: 10.1007/s40264-023-01345-w.


Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals.

Neha R, Beulah E, Anusha B, Vasista S, Stephy C, Subeesh V Int J Clin Pharm. 2020; 42(2):721-727.

PMID: 32270377 DOI: 10.1007/s11096-020-01018-z.


A Primer to the Structure, Content and Linkage of the FDA's Manufacturer and User Facility Device Experience (MAUDE) Files.

Ensign L, Cohen K EGEMS (Wash DC). 2018; 5(1):12.

PMID: 29930960 PMC: 5994953. DOI: 10.5334/egems.221.


Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.

Sarangdhar M, Tabar S, Schmidt C, Kushwaha A, Shah K, Dahlquist J Nat Biotechnol. 2016; 34(7):697-700.

PMID: 27404875 DOI: 10.1038/nbt.3623.